Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer

Yelena Y. Janjigian

Memorial Sloan Kettering Cancer Center, New York

Salah-Eddin Al-Batran

Krankenhaus Nordwest, University Cancer Center (UCT) Frankfurt, and Frankfurt Institute of Clinical Cancer Research (IKF), Frankfurt, Germany

Zev A. Wainberg

Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles

Kei Muro

Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan

Daniela Molena

Division of Thoracic Surgery, Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine, New York

Eric Van Cutsem

University Hospitals Gasthuisberg, Leuven, Belgium

Woo Jin Hyung

Department of Surgery, Yonsei University College of Medicine, Seoul, South Korea

Lucjan Wyrwicz

Department of Oncology and Radiotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland

Do-Youn Oh

Division of Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, and the Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea

Takeshi Omori

Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan

Markus Moehler

Research Center for Immunotherapy (FZI), Johannes Gutenberg-University Clinic, Mainz, Germany

Marcelo Garrido

Hemato-Oncology Department, SAGA Clinical Trial Center and Universidad Mayor, Santiago, Chile

Sulene C.S. Oliveira

Clinical Oncology, Clinical Research Center, Northern Riograndense League Against Cancer, Natal, Brazil

Moishe Liberman

Centre Hospitalier de l’Université de Montréal, Montreal

Victor Castro Oliden

Elizabeth C. Smyth

Oxford NIHR Biomedical Research Centre, Churchill Hospital, Oxford, United Kingdom

Alexander Stein

Mehmet Bilici

Department of Internal Medicine, Division of Medical Oncology, Atatürk University Faculty of Medicine, Erzurum, Turkey

Maria Lorena Alvarenga

Department of Clinical Oncology, Favaloro Foundation University Hospital, Buenos Aires

Vadim Kozlov

State Budgetary Health Care Institution, Novosibirsk Regional Clinical Oncology Dispensary, Novosibirsk, Russia

Fernando Rivera

Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain

Akihito Kawazoe

Olivier Serrano

Cytel, AstraZeneca, Paris

Eric Heilbron

Oncology R&D, Late-Stage Development, AstraZeneca, Gaithersburg, MD

Alejandra Negro

Oncology R&D, Late-Stage Development, AstraZeneca, Gaithersburg, MD

John F. Kurland

Oncology R&D, Late-Stage Development, AstraZeneca, Gaithersburg, MD

Josep Tabernero

Vall d’Hebron Hospital Campus, Barcelona